# Dexilant

NDC: 64764-175
Generic name: dexlansoprazole
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20100412

FDA application: NDA022287

## Active ingredients

- DEXLANSOPRAZOLE: 60 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64764-175"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64764-175
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9819f033-3bbe-442e-8e92-45fec77b237d